Sophia Genetics Gets CE-IVD Mark for Solution to Detect CNVs in BRCA1/2 | GenomeWeb

NEW YORK (GenomeWeb) – Swiss clinical genomics analysis firm Sophia Genetics announced today it has obtained CE-IVD marking for a solution to detect copy number variations in BRCA1 and BRCA2 genes. 

The company has developed an algorithm that directly detects CNVs from next-generation sequencing data. Using the firm's data-driven medicine platform, clinicians can detect all variant types for BRCA1/2 genes in one experiment, it said. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: variation patterns in wheat lines, regulatory variation in Capsella grandiflora, and more.

A Rockefeller University researcher is using edited ants to explore complex biological systems, the New York Times writes.

There's a heritable aspect to how much time people spend online, the Los Angeles Times reports.

Stat News reports that Joseph Gulfo is another contender for FDA commissioner.